A Phase 1 Pharmacokinetic Study of Cysteamine Bitartrate Delayed-Release Capsules Following Oral Administration with Orange Juice, Water, or Omeprazole in Cystinosis

被引：0
|
作者：
Danielle Armas
Robert J. Holt
Nils F. Confer
Gregg C. Checani
Mohammad Obaidi
Yuli Xie
Meg Brannagan
机构：
[1] Celerion Inc.,College of Pharmacy
[2] Horizon Pharma,Clinical Pharmacology and Pharmacometrics
[3] Inc.,undefined
[4] University of Illinois-Chicago,undefined
[5] Celerion Inc.,undefined
[6] Celerion Inc.,undefined
来源：
Advances in Therapy | 2018年 / 35卷
关键词：
Cysteamine bitartrate; Cystinosis; Omeprazole; Pharmacokinetics; Proton pump inhibitor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：199 / 209
页数：10
相关论文
共 11 条
  • [1] A Phase 1 Pharmacokinetic Study of Cysteamine Bitartrate Delayed-Release Capsules Following Oral Administration with Orange Juice, Water, or Omeprazole in Cystinosis
    Armas, Danielle
    Holt, Robert J.
    Confer, Nils F.
    Checani, Gregg C.
    Obaidi, Mohammad
    Xie, Yuli
    Brannagan, Meg
    ADVANCES IN THERAPY, 2018, 35 (02) : 199 - 209
  • [2] Fibrosing colonopathy associated with cysteamine bitartrate delayed-release capsules in cystinosis patients
    Kishk, Omayma A.
    Kim, Ivone
    Cheng, Carmen
    Summan, Mukesh
    Munoz, Monica A.
    PEDIATRIC NEPHROLOGY, 2024, 39 (08) : 2429 - 2433
  • [3] Halitosis in cystinosis patients after administration of immediate-release cysteamine bitartrate compared to delayed-release cysteamine bitartrate
    Besouw, Martine
    Tangerman, Albert
    Cornelissen, Elisabeth
    Rioux, Patrice
    Levtchenko, Elena
    MOLECULAR GENETICS AND METABOLISM, 2012, 107 (1-2) : 234 - 236
  • [4] Long-term clinical benefits of delayed-release cysteamine bitartrate capsules in patients with nephropathic cystinosis (response to "A comparison of immediate release and delayed release cysteamine in 17 patients with nephropathic cystinosis")
    Langman, Craig B. B.
    ORPHANET JOURNAL OF RARE DISEASES, 2023, 18 (01)
  • [5] Long-term clinical benefits of delayed-release cysteamine bitartrate capsules in patients with nephropathic cystinosis (response to “A comparison of immediate release and delayed release cysteamine in 17 patients with nephropathic cystinosis”)
    Craig B. Langman
    Orphanet Journal of Rare Diseases, 18
  • [6] An Open-Label Study to Assess the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Cysteamine Bitartrate Delayed-release Capsules (RP103), Compared to Cysteamine Bitartrate Capsules, (Cystagon®) in Patients with Nephropathic Cystinosis
    Rioux, P.
    Barshop, B.
    PEDIATRIC NEPHROLOGY, 2010, 25 (10) : 2197 - 2197
  • [7] IMPACT OF IMPROVED TREATMENT COMPLIANCE WITH DELAYED-RELEASE CYSTEAMINE BITARTRATE CAPSULES ON THE COSTS OF END STAGE RENAL DISEASE FOR PATIENTS WITH NEPHROPATHIC CYSTINOSIS IN THE UNITED KINGDOM
    Lashilola, Seun
    Xu, Weiwei
    Brandi, Giacomo
    Azimpour, Khashayar
    Carlot, Sara
    PEDIATRIC NEPHROLOGY, 2022, 37 (11) : 2909 - 2910
  • [8] A dose-ranging pharmacokinetic study of nicotine tartrate following delayed-release oral (DRO) and intravenous (IV) administration.
    Compton, RC
    Sandborn, WJ
    Lawson, GM
    Tremaine, WJ
    Zins, BJ
    Mays, DC
    Lipsky, JJ
    Offord, KP
    Hurt, RD
    Evans, BK
    Green, J
    Rhodes, J
    GASTROENTEROLOGY, 1997, 112 (04) : A951 - A951
  • [9] A dose-ranging pharmacokinetic study of nicotine tartrate following single-dose delayed-release oral and intravenous administration
    Compton, RF
    Sandborn, WJ
    Lawson, GM
    Sheets, AJ
    Mays, DC
    Zins, BJ
    Tremaine, WJ
    Lipsky, JJ
    Mahoney, DW
    Zinsmeister, AR
    Offord, KP
    Hurt, RD
    Evans, BK
    Green, J
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1997, 11 (05) : 865 - 874
  • [10] An Open-Label, Dose-Escalation Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of Cysteamine Bitartrate Delayed-release Capsules (RP103) for Treatment of Children with Inherited Mitochondrial Disease (RP103-MITO-001)
    Cohen, Bruce H.
    Enns, Gregory M.
    Haas, Richard
    Longo, Nicola
    Scaglia, Fernando
    Lang, William
    Sile, Saba
    MITOCHONDRION, 2016, 31 : 117 - 117
12